{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T01:14:37Z","timestamp":1787015677329,"version":"build-2736575974"},"reference-count":28,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Canine T-cell lymphoma (TCL) is conventionally considered an aggressive disease, but some forms are histologically and clinically indolent. CD4 TCL is reported to be the most common subtype of TCL. We assessed flow cytometric characteristics, histologic features when available, and clinical outcomes of CD4+ TCL to determine if flow cytometry can be used to subclassify this group of lymphomas.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To test the hypothesis that canine CD4+ T-cell lymphoma (TCL) is a homogeneous group of lymphomas with an aggressive clinical course.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Animals<\/jats:title>\n                    <jats:p>Sixty-seven dogs diagnosed with CD4+ TCL by flow cytometry and treated at 1 of 3 oncology referral clinics.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Retrospective multivariable analysis of outcome in canine CD4+ TCL including patient characteristics, treatment, and flow cytometric features.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The majority of CD4+ TCL were CD45+, expressed low class II MHC, and exhibited an aggressive clinical course independent of treatment regimen (median survival, 159 days). Histologically, CD4+ TCL were classified as lymphoblastic or peripheral T cell. Size of the neoplastic lymphocytes had a modest effect on both PFI and survival in this group. A small number of CD4+ TCL were CD45\u2212 and class II MHC high, and exhibited an apparently more indolent clinical course (median survival not yet reached).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions and Clinical Importance<\/jats:title>\n                    <jats:p>Although the majority of CD4+ TCL in dogs had uniform clinical and flow cytometric features and an aggressive clinical course, a subset had a unique immunophenotype that predicts significantly longer survival. This finding strengthens the utility of flow cytometry to aid in the stratification of canine lymphoma.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/jvim.12304","type":"journal-article","created":{"date-parts":[[2014,2,4]],"date-time":"2014-02-04T13:28:34Z","timestamp":1391520514000},"page":"538-546","source":"Crossref","is-referenced-by-count":68,"title":["Flow Cytometric Characterization and Clinical Outcome of CD4+ T-Cell Lymphoma in Dogs: 67 Cases"],"prefix":"10.1093","volume":"28","author":[{"given":"P.R.","family":"Avery","sequence":"first","affiliation":[{"name":"Immunology and Pathology, College of Veterinary Medicine and Biomedical Sciences, Colorado State University Department of Microbiology, , Fort Collins, CO"},{"name":"Flint Animal Cancer Center, College of Veterinary Medicine and Biomedical Sciences, Colorado State University , Fort Collins, CO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Burton","sequence":"additional","affiliation":[{"name":"Flint Animal Cancer Center, College of Veterinary Medicine and Biomedical Sciences, Colorado State University , Fort Collins, CO"},{"name":"College of Veterinary Medicine and Biomedical Sciences, Colorado State University Department of Clinical Sciences, , Fort Collins, CO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.L.","family":"Bromberek","sequence":"additional","affiliation":[{"name":"College of Veterinary Medicine and Biomedical Sciences, Colorado State University Department of Clinical Sciences, , Fort Collins, CO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.M.","family":"Seelig","sequence":"additional","affiliation":[{"name":"University of Minnesota Department of Veterinary Clinical Sciences, , St. Paul, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Elmslie","sequence":"additional","affiliation":[{"name":"Veterinary Cancer Specialists , Englewood, CO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Correa","sequence":"additional","affiliation":[{"name":"Animal Cancer Care Clinic , Ft. Lauderdale, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.J.","family":"Ehrhart","sequence":"additional","affiliation":[{"name":"Immunology and Pathology, College of Veterinary Medicine and Biomedical Sciences, Colorado State University Department of Microbiology, , Fort Collins, CO"},{"name":"Flint Animal Cancer Center, College of Veterinary Medicine and Biomedical Sciences, Colorado State University , Fort Collins, CO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.S.","family":"Morley","sequence":"additional","affiliation":[{"name":"College of Veterinary Medicine and Biomedical Sciences, Colorado State University Department of Clinical Sciences, , Fort Collins, CO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.C.","family":"Avery","sequence":"additional","affiliation":[{"name":"Immunology and Pathology, College of Veterinary Medicine and Biomedical Sciences, Colorado State University Department of Microbiology, , Fort Collins, CO"},{"name":"Flint Animal Cancer Center, College of Veterinary Medicine and Biomedical Sciences, Colorado State University , Fort Collins, CO"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2014,3,1]]},"reference":[{"key":"2026020304371802600_jvim12304-bib-0001","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.tvjl.2003.10.009","article-title":"Prognostic significance of morphological subtypes in canine malignant lymphomas during chemotherapy","volume":"167","author":"Ponce","year":"2004","journal-title":"Vet J"},{"key":"2026020304371802600_jvim12304-bib-0002","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1354\/vp.43-3-241","article-title":"Canine indolent nodular lymphoma","volume":"43","author":"Valli","year":"2006","journal-title":"Vet Pathol"},{"key":"2026020304371802600_jvim12304-bib-0003","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1177\/104063870501700404","article-title":"Use of fine needle aspirates and flow cytometry for the diagnosis, classification, and immunophenotyping of canine lymphomas","volume":"17","author":"Sozmen","year":"2005","journal-title":"J Vet Diagn Invest"},{"key":"2026020304371802600_jvim12304-bib-0004","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.vetimm.2007.09.018","article-title":"Aberrant phenotypes and quantitative antigen expression in different subtypes of canine lymphoma by flow cytometry","volume":"121","author":"Gelain","year":"2008","journal-title":"Vet Immunol Immunopathol"},{"key":"2026020304371802600_jvim12304-bib-0005","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.vetimm.2008.05.009","article-title":"Immunophenotypic and cytomorphologic subclassification of T-cell lymphoma in the Boxer breed","volume":"125","author":"Lurie","year":"2008","journal-title":"Vet Immunol Immunopathol"},{"key":"2026020304371802600_jvim12304-bib-0006","article-title":"Flow-cytometric detection of phenotypic aberrancies in canine small clear cell lymphoma","volume-title":"Vet Comp Oncol","author":"Martini","year":"2013"},{"key":"2026020304371802600_jvim12304-bib-0007","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1046\/j.1439-0442.2001.00351.x","article-title":"Possibilities of flow cytometric analysis for immunophenotypic characterization of canine lymphoma","volume":"48","author":"Culmsee","year":"2001","journal-title":"J Vet Med A Physiol Pathol Clin Med"},{"key":"2026020304371802600_jvim12304-bib-0008","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1476-5810.2004.00047.x","article-title":"T-cell-derived malignant lymphoma in the Boxer breed","volume":"2","author":"Lurie","year":"2004","journal-title":"Vet Comp Oncol"},{"key":"2026020304371802600_jvim12304-bib-0009","first-page":"169","article-title":"Immunophenotypic characterization of canine lymphoproliferative disorders","volume":"11","author":"Ruslander","year":"1997","journal-title":"In Vivo"},{"key":"2026020304371802600_jvim12304-bib-0010","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1111\/j.1939-1676.2011.0767.x","article-title":"Class II major histocompatibility complex expression and cell size independently predict survival in canine B-cell lymphoma","volume":"25","author":"Rao","year":"2011","journal-title":"J Vet Intern Med"},{"key":"2026020304371802600_jvim12304-bib-0011","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1177\/0300985810379428","article-title":"Classification of canine malignant lymphomas according to the World Health Organization criteria","volume":"48","author":"Valli","year":"2011","journal-title":"Vet Pathol"},{"key":"2026020304371802600_jvim12304-bib-0012","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1111\/j.1939-1676.2009.0289.x","article-title":"Asparaginase and MOPP treatment of dogs with lymphoma","volume":"23","author":"Brodsky","year":"2009","journal-title":"J Vet Intern Med"},{"key":"2026020304371802600_jvim12304-bib-0013","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1476-5829.2010.00230.x","article-title":"CHOP chemotherapy for the treatment of canine multicentric T-cell lymphoma","volume":"9","author":"Rebhun","year":"2011","journal-title":"Vet Comp Oncol"},{"key":"2026020304371802600_jvim12304-bib-0014","first-page":"608","volume-title":"Small Animal Clinical Oncology","author":"Vail","year":"2013","edition":"5th ed"},{"key":"2026020304371802600_jvim12304-bib-0015","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.2460\/javma.237.9.1052","article-title":"Response rate after administration of a single dose of doxorubicin in dogs with B-cell or T-cell lymphoma: 41 cases (2006-2008)","volume":"237","author":"Beaver","year":"2010","journal-title":"J Am Vet Med Assoc"},{"key":"2026020304371802600_jvim12304-bib-0016","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1111\/j.1939-1676.2008.0041.x","article-title":"Canine lymphoproliferative disease characterized by lymphocytosis: Immunophenotypic markers of prognosis","volume":"22","author":"Williams","year":"2008","journal-title":"J Vet Intern Med"},{"key":"2026020304371802600_jvim12304-bib-0017","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1182\/blood-2002-07-1960","article-title":"Peripheral T-cell lymphomas unspecified presenting in the skin: Analysis of prognostic factors in a group of 82 patients","volume":"102","author":"Bekkenk","year":"2003","journal-title":"Blood"},{"key":"2026020304371802600_jvim12304-bib-0018","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1309\/2YGD1P0QCVCWBLDX","article-title":"Adult T-cell leukemia\/lymphoma in Bahia, Brazil: Analysis of prognostic factors in a group of 70 patients","volume":"128","author":"Bittencourt","year":"2007","journal-title":"Am J Clin Pathol"},{"key":"2026020304371802600_jvim12304-bib-0019","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1182\/blood-2003-09-3080","article-title":"Peripheral T-cell lymphoma unspecified (PTCL-U): A new prognostic model from a retrospective multicentric clinical study","volume":"103","author":"Gallamini","year":"2004","journal-title":"Blood"},{"key":"2026020304371802600_jvim12304-bib-0020","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1093\/annonc\/mdm012","article-title":"Immunophenotype as prognostic factor for diffuse large B-cell lymphoma in patients undergoing clinical risk-adapted therapy","volume":"18","author":"Veelken","year":"2007","journal-title":"Ann Oncol"},{"key":"2026020304371802600_jvim12304-bib-0021","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1080\/10428190601078605","article-title":"HLA-DR protein status predicts survival in patients with diffuse large B-cell lymphoma treated on the MACOP-B chemotherapy regimen","volume":"48","author":"Rimsza","year":"2007","journal-title":"Leuk Lymphoma"},{"key":"2026020304371802600_jvim12304-bib-0022","doi-asserted-by":"crossref","first-page":"4251","DOI":"10.1182\/blood-2003-07-2365","article-title":"Loss of MHC class II gene and protein expression in diffuse large B-cell lymphoma is related to decreased tumor immunosurveillance and poor patient survival regardless of other prognostic factors: A follow-up study from the Leukemia and Lymphoma Molecular Profiling Project","volume":"103","author":"Rimsza","year":"2004","journal-title":"Blood"},{"key":"2026020304371802600_jvim12304-bib-0023","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1309\/2QE3A6EKQ8UYDYRC","article-title":"Precursor T-cell acute lymphoblastic leukemia\/lymphoblastic lymphoma and acute biphenotypic leukemias","volume":"127","author":"Han","year":"2007","journal-title":"Am J Clin Pathol"},{"key":"2026020304371802600_jvim12304-bib-0024","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1399-0039.1985.tb00448.x","article-title":"Class II antigens on canine T lymphocytes","volume":"25","author":"Doveren","year":"1985","journal-title":"Tissue Antigens"},{"key":"2026020304371802600_jvim12304-bib-0025","doi-asserted-by":"crossref","first-page":"763","DOI":"10.4049\/jimmunol.168.2.763","article-title":"Activated human T cells accomplish MHC class II expression through T cell-specific occupation of class II transactivator promoter III","volume":"168","author":"Holling","year":"2002","journal-title":"J Immunol"},{"key":"2026020304371802600_jvim12304-bib-0026","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1177\/0300985812465325","article-title":"Molecular profiling reveals prognostically significant subtypes of canine lymphoma","volume":"50","author":"Frantz","year":"2013","journal-title":"Vet Pathol"},{"key":"2026020304371802600_jvim12304-bib-0027","article-title":"Canine indolent and aggressive lymphoma: Clinical spectrum with histologic correlation","volume-title":"Vet Comp Oncol","author":"Aresu","year":"2013"},{"key":"2026020304371802600_jvim12304-bib-0028","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1476-5829.2011.00317.x","article-title":"Clinical, histopathological and immunohistochemical characterization of canine indolent lymphoma","volume":"11","author":"Flood-Knapik","year":"2012","journal-title":"Vet Comp Oncol"}],"container-title":["Journal of Veterinary Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjvim.12304","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjvim.12304","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jvim\/article-pdf\/28\/2\/538\/66685700\/jvim12304.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jvim\/article-pdf\/28\/2\/538\/66685700\/jvim12304.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T09:37:56Z","timestamp":1770111476000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jvim\/article\/28\/2\/538\/8452082"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,1]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,3,1]]}},"URL":"https:\/\/doi.org\/10.1111\/jvim.12304","relation":{},"ISSN":["1939-1676"],"issn-type":[{"value":"1939-1676","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2014,3]]},"published":{"date-parts":[[2014,3,1]]}}}